The online-only Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/doi:10.1161/CIRCEP.112.973164/-/DC1. Correspondence to Ravi Ranjan, MD, PhD, Division of Cardiology, University of Utah, CARMA Center, 30 N 1900 E, Room 4A100, Salt Lake City, UT 84132. E-mail ravi.ranjan@hsc.uah.edu Background-Radiofrequency ablation is routinely used to treat cardiac arrhythmias, but gaps remain in ablation lesion sets because there is no direct visualization of ablation-related changes. In this study, we acutely identify and target gaps using a real-time magnetic resonance imaging (RT-MRI) system, leading to a complete and transmural ablation in the atrium. Methods and Results-A swine model was used for these studies (n=12). Ablation lesions with a gap were created in the atrium using fluoroscopy and an electroanatomic system in the first group (n=5). The animal was then moved to a 3-tesla MRI system where high-resolution late gadolinium enhancement MRI was used to identify the gap. Using an RT-MRI catheter navigation and visualization system, the gap area was ablated in the MR scanner. In a second group (n=7), ablation lesions with varying gaps in between were created under RT-MRI guidance, and gap lengths determined using late gadolinium enhancement MR images were correlated with gap length measured from gross pathology. Gaps up to 1.0 mm were identified using gross pathology, and gaps up to 1.4 mm were identified using late gadolinium enhancement MRI. Using an RT-MRI system with active catheter navigation gaps can be targeted acutely, leading to lesion sets with no gaps. The correlation coefficient (R 2 ) between the gap length was identified using MRI, and the gross pathology was 0.95. 
R adiofrequency ablation is routinely used to target numerous cardiac arrhythmias, such as ventricular tachycardia and atrial fibrillation. 1, 2 In many of these procedures, the goal of the ablation procedure is to electrically isolate one region of the myocardium from another. 3 When ablating for atrial fibrillation, the goal is to achieve electric isolation of the pulmonary veins. 4 Yet, despite the best efforts, the success rate for some ablation procedures like those for atrial fibrillation ranges from 40% to 80%. 5, 6 One of the reasons for the low procedural success is the presence of gaps in ablation lesion sets. [7] [8] [9] In the current ablation procedures, there is no direct visualization of changes in the tissue, and ablation is inferred based on numerous indirect parameters, such as local electrogram attenuation, power delivered, and temperature at the catheter tip. None of these are completely reliable measures of ablation and can result in ablation lesions sets with gaps.
Magnetic resonance imaging (MRI) has excellent soft tissue visualization capability, which can be used to identify ablation lesions. 10, 11 Here, we report using MRI to acutely identify ablation lesions and accurately determine gaps in ablation lesion sets. We then describe using a real time MRI system to acutely target and ablate these gap areas in the ablation lesion set. In addition, we characterize the smallest gaps that can be identified using the real-time MRI system. A method to identify ablation lesions and gaps in between them and the ability to target these gaps acutely can potentially result in significant improvement in the outcome of these procedures.
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Methods
Animal Preparation
A swine model was used for the study. The Institutional Animal Care and Use Committee approved the study. Animals weighing 30 to 35 kg (n=12) were used and were given a preanesthetic cocktail of telazol 4.4 mg/kg, ketamine 2.2 mg/kg, and xylazine 2.2 mg/kg intramuscularly. For anesthesia, 20 to 40 minutes later they were given 20 to 60 mg/kg of pentobarbital intravenously. They were maintained in deep anesthesia by giving periodic intravenous injections of 30 to 40 mg/kg of pentobarbital. The animals were mechanically ventilated. Venous access to the femoral veins and femoral artery was obtained by a cut-down approach to the blood vessels. Sheaths of 11F (St Jude Medical, Austin, TX) were placed in the right and left femoral vein and were used to insert the mapping and ablation catheter. A 6F sheath was placed in the right femoral artery and was used for blood pressure monitoring and for obtaining periodic arterial sample for arterial blood gas analysis during the study. Two groups of animals were used for the study. After being anesthetized, the animals in the first group (n=5) were taken to the electrophysiology laboratory with a fluoroscopy system, and ablation lesions were created as described below. The animals in the second group (n=7) were taken directly to the real-time MRI (RT-MRI) system after being anesthetized for ablation and identification of the gap as described in the section Visualizing Gap Between Ablation Lesions Using MRI.
Electrophysiology Studies Using Fluoroscopy
Anesthetized animal from the first group (n=5) was moved to the electrophysiology laboratory with a fluoroscopy (Artis Zeego; Siemens USA, Malvern, PA) and an electroanatomic mapping system. CARTO (Biosense Webster, Diamond Bar, CA) electroanatomic mapping system was used for electrophysiology studies. A nonirrigated 4-mm-tip NaviStar (Biosense Webster) catheter was used for electroanatomic mapping. The catheter was advanced to the right atrium (RA) via the sheath in the right femoral vein. A baseline voltage map of the RA was made. Two discrete ablation lesions were made in the RA spaced about a centimeter apart. Ablation was done in a temperature-controlled mode with a 60° cut-off and a power of 30 W for 30 seconds. After the ablation, a new voltage map was created to confirm the low-voltage areas in the ablated areas and normal voltage in the gap in between. After the electrophysiology study, the NaviStar catheter was removed and the animal was checked to make sure it was free of any ferromagnetic materials. It was then moved to the MR scanner.
Electrophysiology Study in the MRI Scanner
After the ablation in the fluoroscopy suite, the animal was moved to the MRI suite with a 3-tesla MRI scanner (Verio; Siemens Healthcare, Erlangen, Germany). MRI-compatible ECG electrodes were put on the chest and connected to an MRI-compatible monitoring system (Veris MR; Medrad Inc, Warrendale, PA) for ECG, blood pressure, and oxygen saturation monitoring. The total time from the end of ablation in the fluoroscopy suite to the beginning of MR image acquisition was less than an hour. A gadolinium-based MRI contrast agent (Multihance; Bracco Diagnostic Inc, Princeton, NJ) was injected, and magnetic resonance angiogram (MRA) of the whole heart was acquired. MRA was performed during slow infusion of gadolinium-based contrast agent (dose=0.15 mmol/kg; infusion rate=0.1 mmol/s; Multihance; Bracco Diagnostic Inc). MRA images were acquired using a 3-dimensional (3D) respiratory navigated and ECG-gated gradient-recalled echo pulse sequence, with echo time/ repetition time of 1.3/2.9 ms, flip angle of 23°, bandwidth of 870 Hz/pixel, field of view (FOV) of 240 × 240 × 120 mm, matrix size of 192 × 192 × 48, 25% oversampling in slice-encoding direction, voxel size of 1.25 × 1.25 × 2.5 mm, and phase-encoding direction of left to right. The data acquisition was limited to 20% of cardiac cycle and was performed during the stationary (diastolic) phase of RA. Twenty minutes after contrast injection, late gadolinium enhancement (LGE) images with spatial resolution of 1.25 × 1.25 × 2.5 mm were acquired. The LGE images were acquired using a 3D respiratory-navigated, inversion recovery-prepared gradient-recalled echo pulse sequence with echo time of 1.4 ms, repetition time of 3.1 ms, flip angle of 14°, bandwidth of 780 Hz/pixel, FOV of 240 × 240 × 110 mm, matrix size of 192 × 192 × 40, 10% oversampling in slice-encoding direction, voxel size of 1.25 × 1.25 × 2.5 mm, and phase-encoding direction of left to right. Inversion pulse was applied to every heart beat, and fat saturation was applied immediately before data acquisition. Timing for data acquisition was found from cine images of RA. The data acquisition was limited to 15% of cardiac cycle and was performed during the stationary phase of RA.
The RA geometry was segmented from the MRA image volume using Seg3D 2.0 (Scientific and Computing Institute, University of Utah). Specifically, the contrast-enhanced blood pool was isolated using a user-defined threshold. A surface mesh of the RA was then generated from the segmentation using SCIRun 4.6 (Scientific and Computing Institute, University of Utah). The ablation lesions were observed and segmented from the LGE-MRI scan using Seg3D 2.0 based on acute contrast enhancement. Geometric models of the lesions were then created using SCIRun 4.6 and imported concurrently with the MRA-derived RA model in the real-time MRI visualization and navigation interface interactive front end (Siemens Corporate Research, Princeton, NJ). RT-MRI guidance of the catheter movement during mapping and ablation was provided by the interactive real-time tip tracking pulse sequence and the interactive front end navigation and visualization software (Siemens Corporate Research, Princeton, NJ). The catheter was visualized during navigation with an RT-MRI sequence (radiofrequency-spoiled gradient-recalled echo pulse sequence with a frame rate of ≈5 frames per second), and 4 tracking microcoils near the tip of the custom MRI-compatible catheter (MRI Interventions Inc, Irvine, CA) allowed for accurate detection of the catheter position in 3D space. Real-time images were acquired sequentially in multiple slices and rendered in 3D at their respective locations. Typical scan parameters for RT sequence were as follows: echo time, 1.5 ms; repetition time, 3.3 ms; flip angle, 13°; bandwidth, 750 Hz/pixel; spatial resolution, 1.8 × 2.0 mm; and slice thickness, 5 mm.
An 8F, 3-tesla MR-compatible, irrigated, temperature sensing, mapping, and ablation catheter (MRI Interventions, Irvine, CA), described earlier, 12 was inserted into the RA via the right femoral vein. The RT-MRI visualization interface with the shell of the RA was used to guide the catheter movement, along with the surface ECG and intracardiac electrograms recorded by the catheter. The tip of the catheter was positioned on the more cranial lesion, and under RT-MRI guidance the gap area between the 2 lesions was ablated. The MRIcompatible catheter was connected to a standard radiofrequency ablation unit (Stockert-70, radiofrequency generator; Biosense Webster) with custom-built interface for the MRI-compatible catheters. A power setting of 30 W was used to ablate in the atrium. After ablation in the MR scanner, gadolinium contrast agent was infused again and LGE images were acquired. After imaging, the animals were injected with triphenyltetrazolium chloride and the animals were euthanized with intravenous potassium chloride. Triphenyltetrazolium chloride stains live tissue red in color, clearly demarcating ablated and infarcted areas. 13, 14 The animal chest was opened and the heart excised for further examination. The endocardial surface of the RA was exposed by making a linear incision from the inferior to the superior vena cava. The ablated lesions were visually inspected, and tissues were excised for histology.
Visualizing Gap Between Ablation Lesions Using MRI
For this part of the project, the second set of animals (n=7) were prepared as described above, except that instead of making lesions in the fluoroscopy suite, the animals were taken directly to the MRI scanner. MRA was acquired using a gadolinium-based contrast agent, as described above. From the MRA images, the RA was segmented and meshed (using Seg3D 2.0 and SCIRun 4.6, respectively) and imported in the real-time catheter visualization software interface. MRI-compatible catheter described above was inserted in the right femoral vein and advanced to the RA using RT-MRI guidance. Using the segmented shell of the RA and with RT-MRI guidance, discrete ablation lesions were made in the RA. To minimize the number of animals, paired lesions with varying gaps between the ablation lesions were made in distinct parts of the RA. These lesions were made in the temperature-controlled mode set at 60° and 30 W. The ablation was carried out for 30 seconds. After the lesions were made,
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LGE MR images were acquired. The LGE images had a spatial resolution of 1.0 × 1.0 × 1.5 mm. Subsequently, triphenyltetrazolium chloride was injected, and the animal was euthanized using intravenous potassium chloride. The chest was opened and the heart excised for further examination. The gap between the lesions was measured on the endocardial surface. Eight of the ablated lesion pairs with the gap in between underwent hematoxylin and eosin and Masson trichrome staining to further characterize the gap and the ablated areas. For histology, the tissue was fixed in formalin and then embedded in a paraffin block. Once embedded in the block, sections were obtained and stained with hematoxylin and eosin and Masson trichrome. The 3D LGE MR images were processed using Osirix (Osirix Imaging Software, Pixmeo, Geneva, Switzerland). A higher-resolution 3D data set with a resolution of 0.5 × 0.5 × 1.0 mm was created by interpolating the data. The 3D image set was visualized using the 3D multiplanar reconstruction technique. The measurement tool was used to quantify the gap length between the ablation lesions.
Statistical Analysis
The gap length between the ablation lesions determined from the endocardial surface of gross pathology was correlated with the gap length determined from the 3D LGE MR images. The correlation coefficient was determined for the 2 measurements.
Results
Filing the Gap Using Real-Time MRI
At baseline, none of the animals showed any areas of low voltage in the RA. After obtaining a baseline voltage map, 2 discrete ablation lesions were made in the RA. The new voltage map created after the lesions showed discrete areas of low voltage at the ablation sites and normal voltage in the gap area between the lesions (online-only Data Supplement Figure I) .
After creating the ablation lesions in the fluoroscopy suite, the animal was moved to the MR scanner. In the MR scanner, MRA and LGE images were acquired identifying the ablation lesions. Figure 1 depicts LGE images showing the 2 discrete lesions in the RA in the axial (A and B), coronal (C), and sagittal (D) planes. The MRA and LGE images were segmented to create a shell of the RA and identify ablated lesions with the gap in between. This image was uploaded in the realtime MRI visualization and navigation interface at the MR scanner. Figure 2 is a screen shot of the real-time navigation system in the MRI, showing the RA shell, the ablated lesions, and the catheter in between. The real-time navigation system was used to position the catheter at the previously ablated areas and guide its navigation to ablate the gap between the 2 lesions. In addition to using the RA shell, the location of the previously ablated lesions on the shell and real-time MR images through different planes and the lack of local bipolar electrogram were used to confirm the location of previously ablated areas. After ablating the gap area, the LGE images were reacquired, confirming that the gap between the previously ablated lesions was also ablated. Figure 3 illustrates LGE images with the gap area between the lesions ablated in axial (A and B), coronal (C), and sagittal (D) planes.
Gross Pathology and Histology
The RA tissue around the ablated area was excised for gross examination and histological examination. On gross examination, a continuous set of lesions was confirmed. Cut sections on gross pathology and Masson trichrome staining confirmed the ablation and its transmurality (online-only Data Supplement Figure II) .
Minimum Gap Length Detected by MRI
Ablation lesions with varying distance between them were made in the RA. The gap length as measured in the endocardial surface was compared with the gap length as measured Screen shot of the real-time magnetic resonance imaging navigation system. On the left are 3 magnetic resonance images in 3 perpendicular planes. The location of these planes can be adjusted by the user for optimal performance. Right, A sagittal viewing plane with the shell of the right atrium (in orange) and the ablated lesions (marked in purple with blue and green arrows) imported to the real-time catheter navigation interface. In this image, the catheter tip is in the gap area between the 2 ablation lesions.
in the 3D LGE MR image set. Figure 4 shows a typical MR image of a pair of ablation lesion with the gap in between. Figure 4A and 4B represents perpendicular planes through the same pair of lesions in the RA. Figure 4C and 4D represents magnified images shown in panels A and B, with the gap between the lesions marked using the measurement tool in Osirix.
The gap length as determined by the gross pathology (online-only Data Supplement Figure III) was correlated with the gap length determined in the LGE MR images. Figure 5 shows the correlation between the gap length as determined by MRI, with the gap length determined by gross pathology. The correlation coefficient (R 2 ) is 0.95.
Discussion
Currently, when ablating for atrial fibrillation, the goal is to achieve electric isolation of all the pulmonary veins. 4 Hence, when ablating and after making the initial set of ablation lesions, the electric isolation of the pulmonary vein is checked using a functional assay typically using a multipole lasso catheter. If the veins are not electrically isolated, the lasso catheter is used to guide further ablation to isolate the veins. Using the lasso catheter allows to assess gaps that are electrically active and conducting, but it provides no feedback on the changes from ablation in the myocardial tissue itself. Furthermore, with the use of lasso catheter, one cannot identify gaps if they are electrically silent, and electric isolation has been achieved despite the presence of gaps. Other techniques such as pacing from the ablation line to capture the surrounding tissue have been reported to assess for completeness of ablation. 15 Despite the use of these tests to eliminate gaps in ablation lesion sets, pulmonary vein reconnection continues to occur over time.
In numerous studies when patients were brought back for redo procedures because of arrhythmia recurrence, the pulmonary veins isolated at the index procedures were no more electrically isolated. 7, 16 The time course of recovery of conduction across previously isolated pulmonary veins is quite variable. In a human study, within just an hour after completing the pulmonary vein isolation, it was found that 30% of the pulmonary veins were reconnected. 17 Reisolating these veins resulted in an improvement in the outcome, with a lower recurrence rate for atrial fibrillation. 17 In an animal study, looking at changes in the action potential duration as a result of ablation, it was found that acutely there was a gradation in action potential changes, with the largest change occurring at the boundary of the ablated region. The action potential duration gradually approached normal ≈3 mm away from the ablation margin. 18 After about just a week, the action potential had recovered completely all the way to the edge of the ablated area. 18 It has also been shown in an animal study that one can have electric isolation, despite the presence of gaps in myocardial tissue. 19 Using the current assay of a lasso catheter to identify and acutely target any gap areas, we miss these electrically silent gaps. Furthermore, it has been shown in a computational model that gaps, which might not be conducting acutely, can start conducting, with the recovery of some conductivity potentially leading to arrhythmia recurrence. 19 As a result, using only electric conductivity as an end point for isolation is not enough to have long-term electric isolation. To make the electric isolation more permanent, there is a need for direct visualization of changes at the tissue level from ablation and identification of gaps in the ablation lesion sets. MRI has excellent soft tissue visualization characteristics and has been used to identify ablated areas, 20 and effort has been made to develop MRI-based electrophysiology ablation system. 12, 21 Here, for the first time we have used MRI to accurately identify gaps in ablation lesions immediately after ablation and then target them acutely using real-time catheter visualization. Although few other groups have attempted developing a real-time MRI system, applying it to acutely identify and target gaps in ablation lesions is novel and to the best of our knowledge has not been reported before. 22, 23 This acute targeting of gaps in lesion sets will lead to more robust electric isolation by creating lesion sets without any gaps.
In conclusion, we have used the excellent soft tissue visualization capabilities of MRI to accurately identify gaps in ablation lesion sets and, then, using a real-time MRI system have shown that these gaps can be targeted acutely. This can lead to more robust ablation lesions, potentially improving clinical outcomes over time.
Limitations
The resolution of the gaps that can be detected by MRI in this study was in the millimeter range. Although submillimeter gaps are within the limits of gaps that can be tolerated in certain situations as predicted by computational models, a higher resolution will likely lead to better results. 19 This can be achieved with higher-resolution scans requiring further improvement in technology and longer scan times.
